Michele Stanislaw Milella

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

Marina Chiara Garassino, Byoung Chul Cho, Joo-Hang Kim et al. · The Lancet Oncology · 2018 · 568 citations · Full text

Medicine, Immunology, Pathology +5

A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

Wei Jiao, Gurnit Atwal, Paz Polak et al. · Nature Communications · 2020 · 230 citations · Full text

Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials

Solko W. Schalm, Ola Weiland, Bettina E. Hansen et al. · Gastroenterology · 1999 · 156 citations · Full text

Hepatology, Hepatitis C, Viral Hepatitis +11

Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon

Giuseppe Pastore, Teresa Santantonio, Michele Stanislaw Milella et al. · Journal of Hepatology · 1992 · 108 citations

Vaccination, Serum Response, Viral Persistence +11

A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study

Flavia Novelli, Michele Stanislaw Milella, Elisa Melucci et al. · Breast Cancer Research · 2008 · 104 citations · Full text